Non response | Response | p-value | |||
---|---|---|---|---|---|
n | % | n | % | ||
Primary malignancy | 0.794 | ||||
Uterus | 9 | 75 | 3 | 25 | |
Ovary | 6 | 55 | 5 | 45 | |
Cervix | 5 | 71 | 2 | 29 | |
Vulva | 2 | 67 | 1 | 33 | |
Fallopian tube | 1 | 100 | 0 | 0 | |
KPS | 0.037 | ||||
≤70% | 10 | 71 | 4 | 29 | |
> 70% | 7 | 40 | 13 | 60 | |
Chemotherapy prior to RT | 0.046 | ||||
Yes | 12 | 86 | 2 | 14 | |
No | 11 | 55 | 9 | 45 | |
Location of spinal metastases | 0.279 | ||||
Thoracic | 9 | 75 | 3 | 25 | |
Thoracic and lumbar | 3 | 100 | 0 | 0 | |
Lumbar | 11 | 58 | 8 | 42 | |
Bisphosphonates during RT | 0.914 | ||||
Yes | 10 | 67 | 5 | 33 | |
No | 13 | 68 | 6 | 32 | |
Surgical corset | 0.523 | ||||
Yes | 4 | 80 | 1 | 20 | |
No | 19 | 65 | 10 | 35 |